Ipsen SA annual operating income
2020
2021
2022
2023
2024
2025
Ipsen SA Operating Income Growth & History (IPN)
Ipsen SA's operating income was €945.1M for fiscal 2025.
View full Ipsen SA company overviewIpsen SA annual operating income history
| Fiscal year | Period ended | Operating income | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €945.1M | €448.4M | +90.28% |
| 2024 | 2024-12-31 | €496.7M | −€319.3M | −39.13% |
| 2023 | 2023-12-31 | €816.0M | €86.1M | +11.80% |
| 2022 | 2022-12-31 | €729.9M | −€94.8M | −11.50% |
| 2021 | 2021-12-31 | €824.7M | €299.9M | +57.15% |
| 2020 | 2020-12-31 | €524.8M | — | — |
Ipsen SA operating income trends
Over the last five fiscal years, Ipsen SA's operating income increased from €524.8M to €945.1M, a change of €420.3M.
About the metric
What operating income means
Operating income is the profit or loss a company generates from its core business after cost of revenue and operating expenses, but before non-operating items such as interest and income taxes.
Calculation and source
reported operating income
TickerStat standardizes operating income reported in company official filings for aligned fiscal periods. It is not adjusted EBIT, an analyst estimate, or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ipsen SA source filings ↗Community posts
Ipsen lifts annual growth and margin forecasts after strong drug sales
Ipsen ($IPN) raised its 2026 sales-growth target to approximately 23% at constant exchange rates, from more than 20%, and its core operating-margin forecast to around 39%, from above 37%. Third-quarter revenue reached €1.17 billion, increas ...
